PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 133 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $413,000 | +103.4% | 55,300 | +61.7% | 0.01% | +150.0% |
Q4 2017 | $203,000 | -25.4% | 34,200 | -7.3% | 0.00% | -33.3% |
Q3 2017 | $272,000 | -11.1% | 36,900 | -18.2% | 0.00% | -25.0% |
Q2 2017 | $306,000 | +18.1% | 45,100 | +64.6% | 0.00% | +33.3% |
Q1 2017 | $259,000 | +488.6% | 27,400 | +163.5% | 0.00% | +200.0% |
Q2 2016 | $44,000 | -84.9% | 10,400 | -78.2% | 0.00% | -75.0% |
Q4 2015 | $292,000 | +87.2% | 47,600 | +74.4% | 0.00% | +100.0% |
Q3 2015 | $156,000 | – | 27,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |